Name: genetics of dyslipidemia (en Inglés)
Price: 195990.00 CLP
Availability: InStock
Author: benlian
ISBN: 9780792373629

portada genetics of dyslipidemia (en Inglés)

Formato

Libro Físico

Editorial

springer publishing map

Autor

benlian

Idioma

Inglés

N° páginas

328

ISBN

0792373626

ISBN13

9780792373629

Categorías

Enfermedades cardiovasculares

genetics of dyslipidemia (en Inglés)

Benlian (Autor) · springer publishing map · Libro Físico

Libro Nuevo

$ 195.990

$ 391.980

Ahorras: $ 195.990

50% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Jueves 11 de Julio y el Jueves 18 de Julio.

Lo recibirás en cualquier lugar de Chile entre 1 y 3 días hábiles luego del envío.

Reseña del libro "genetics of dyslipidemia (en Inglés)"

profound mortality rates, due to cardiovascular disease, are a worldwide problem. cardiovascular disease results from complications of a silent and chronic arterial disease: atherosclerosis. the challenge for the practitioner is adapting diagnostic and therapeutic responses to prevent this common and complex disease. dyslipidemia, are disorders of the metabolism of soluble transporters of lipids in extracellular spaces of the human body (including blood), called lipoproteins. they are major cardiovascular risk factors, causally related with atherosclerosis and are themselves multifactorial diseases, resulting from interactions between genetic and environmental factors. the study of genetic factors has recently taken a new path with the study of dna as an experimental object. more than fifty genes of lipoprotein metabolism have been identified in both their physiological actions and their contribution to the pathogenesis of human dyslipidemia. the diversity of observations has refined our current knowledge of the control of lipid metabolism and energy homeostasis in living organisms beyond the limits of the cardiovascular system (e.g., brain, immune system, and development). these studies have given way to a shake-up of former phenotypic classifications, distinguishing new entities, defining targeted therapeutic strategies, providing a basis for different patterns of disease distribution in human populations.